May 6, 2019 from 12-1PM EST. Join presenter Krista L. Lanctot, PhD as she outlines the rational for use of cannabinoids, reviews previous literature assessing the efficacy of THC and related compounds for agitation, and presents results of the most recent trial of a cannabinoid for agitation. Register here.
Tues. April 23, 2019 from 12-1PM EST. Join Marjorie Silverman, Ph.D. for this free brainxchange webinar presentation as she shares findings from an Ottawa-based research study funded by the Alzheimer Society of Canada. To learn more or to register click here.
On May 6th, 2019 presenter Dr. Susan Crocker, a clinical cytogeneticist and Director of the Cytogenetics Laborartory at Kingston Health Sciences Centre (KHSC)reviewed aspects of the current knowledge of neurogenesis; explores the role of cytogenomic aberrations and their presence in the neuropathology of the brain and discusses the utility of recent advances in molecular testing and their potential application to screening for neurodegenerative disease. Stay tuned for the recording of the presentation here.
May 30, 2019 from 8am-4pm at the Holiday Inn Toronto-Yorkdale the RGPs of Ontario is pleased present "Optimizing the Integration of Geriatric Medicine and Geriatric Psychiatry Services" for health professionals, administrators, planners, students and older adults / family caregiver advisory group members. Register here.
May 6-8, 2019 at the Sheraton Centre Hotel, Toronto. This three day Annual General Meeting and Convention is a must-attend annual event for professionals who work in senior care. To learn more or to register click here.
Baycrest, in partnership with North East Specialized Geriatric Centre, is excited to announce Cycle 4 of “Project ECHO Care of the Elderly” (ECHO COE), a telehealth education program with didactic presentations and case-based learning that aims to help primary care providers build capacity in the care of older adults. The sessions run weekly from April 10 – July 17, 2019 on Wednesdays from 3:00-4:30 PM EST. For more information, please see the pdf downloads or click here.
This UK report aims to raise awareness of an often overlooked population, to promote greater understanding of support needs and recommend approaches that offer better, high quality care. 16 pages. Last reviewed March 2019.
This publication summarizes the literature on the evidence of using endocannabinoid system medications and their ability to modulate neuroinflammation and oxidative stress in Alzheimer’s Disease. 15 pages. Last reviewed March 2019.
This article reviews the findings of a randomized, double-blind, placebo-controlled study that sought evidence for the efficacy of low-dose TCH in reducing neuropsychiatric symptoms of dementia. 9 pages. Last reviewed March 2019.